Counting all the costs: The economic impact of comorbidity

Key Issues in Mental Health

Volumn 179, Issue , 2015, Pages 23-32

  McDaid, David ^a,b   Park, A La ^a  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^b EUROPEAN OBSERVATORY ON HEALTH SYSTEMS AND POLICIES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929631065     PISSN: 16624874     EISSN: 16624882     Source Type: Book Series    
DOI: 10.1159/000365941     Document Type: Review

References (39)

1. Naylor C, Parsonage M, McDaid D, Knapp M, Fossey M, Galea A: LongTerm Conditions and Mental Health. The Costs of Co-Morbidities. London, The King's Fund, 2012.
2. Wittchen HU, Jacobi F, Rehm J, Gus-tavsson A, Svensson M, Jonsson B, et al: The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharma-col 2011; 21:655-679.
3. Wahlbeck K, Westman J, Nordentoft M, Gissler M, Laursen TM: Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders. Br J Psychiatry 2011; 199:453-458.
4. McDaid D, Park A-L, Currie C, Zanotti C: Investing in the wellbeing of young people: making the economic case; in McDaid D, Cooper CL (eds): Wellbeing: A Complete Reference Guide. The Economics of Wellbeing. Oxford, John Wiley, 2014, vol 5.
5. Chwastiak LA, Rosenheck RA, McEvoy JP, Stroup TS, Swartz MS, Davis SM, et al: The impact of obesity on health care costs among persons with schizophrenia. Gen Hosp Psychiatry 2009; 31:1-7.
6. McDonald M, Hertz RP, Lustik MB, Un-ger AN: Healthcare spending among community-dwelling adults with schizophrenia. Am J Manag Care 2005; 11(8 suppl):S242-S247.
7. Hendrie HC, Tu W, Tabbey R, Purnell CE, Ambuehl RJ, Callahan CM: Health outcomes and cost of care among older adults with schizophrenia: a 10-year study using medical records across the continuum of care. Am J Geriatr Psychiatry 2014; 22:427-436.
8. Centorrino F, Mark TL, Talamo A, Oh K, Chang J: Health and economic burden of metabolic comorbidity among individuals with bipolar disorder. J Clin Psychopharmacol 2009; 29:595-600.
9. Guo JJ, Keck PE Jr, Li H, Jang R, Kelton CM: Treatment costs and health care utilization for patients with bipolar disorder in a large managed care population. Value Health 2008; 11:416-423.
10. Welch CA, Czerwinski D, Ghimire B, Bertsimas D: Depression and costs of health care. Psychosomatics 2009; 50: 392-401.
11. Hutter N, Schnurr A, Baumeister H: Healthcare costs in patients with diabetes mellitus and comorbid mental disorders-a systematic review. Diabetologia 2010; 53:2470-2479.
12. Molosankwe I, Patel A, Jose Gagliardino J, Knapp M, McDaid D: Economic aspects of the association between diabetes and depression: a systematic review. J Affect Disord 2012; 142(suppl):S42-S55.
13. Le TK, Curtis B, Kahle-Wrobleski K, Johnston J, Haldane D, Melfi C: Treatment patterns and resource use among patients with comorbid diabetes melli-tus and major depressive disorder. J Med Econ 2011; 14:440-447.
14. Atlantis E, Goldney RD, Eckert KA, Taylor AW, Phillips P: Trends in health-related quality of life and health service use associated with comorbid diabetes and major depression in South Australia, 1998-2008. Soc Psychiatry Psychiatr Epidemiol 2012; 47:871-877.
15. Simon GE, Katon WJ, Lin EH, Ludman E, VonKorff M, Ciechanowski P, et al: Diabetes complications and depression as predictors of health service costs. Gen Hosp Psychiatry 2005; 27:344-351.
16. Boulanger L, Zhao Y, Foster TS, Fraser K, Bledsoe SL, Russell MW: Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain. Curr Med Res Opin 2009; 25:1763-1773.
17. Unutzer J, Schoenbaum M, Katon WJ, Fan MY, Pincus HA, Hogan D, et al: Healthcare costs associated with depression in medically Ill fee-for-service Medicare participants. J Am Geriatr Soc 2009; 57:506-510.
18. Brilleman SL, Purdy S, Salisbury C, Windmeijer F, Gravelle H, Hollinghurst S: Implications of comorbidity for primary care costs in the UK: a retrospective observational study. Br J Gen Pract 2013; 63:e274-e282.
19. Subramaniam M, Sum CF, Pek E, Stahl D, Verma S, Liow PH, et al: Comorbid depression and increased health care utilisation in individuals with diabetes. Gen Hosp Psychiatry 2009; 31:220-224.
20. Vamos EP, Mucsi I, Keszei A, Kopp MS, Novak M: Comorbid depression is associated with increased healthcare utilization and lost productivity in persons with diabetes: a large nationally representative Hungarian population survey. Psychosom Med 2009; 71:501-507.
21. Sicras Mainar A, Rejas Gutierrez J, Na-varro Artieda R, Serrat Tarres J, Blanca Tamayo M, Diaz Cerezo S: Patterns of health services use and costs in patients with mental disorders in primary care (in Spanish). Gac Sanit 2007; 21:306-313.
22. Royal College of Physicians, Royal College of Psychiatrists: Smoking and Mental Health. London, Royal College of Physicians, 2013.
23. Hochlehnert A, Niehoff D, Wild B, Jünger J, Herzog W, Löwe B: Psychiatric comorbidity in cardiovascular inpa-tients: costs, net gain, and length of hos-pitalization. J Psychosom Res 2011; 70: 135-139.
24. Hutter N, Knecht A, Baumeister H: Health care costs in persons with asthma and comorbid mental disorders: a systematic review. Gen Hosp Psychiatry 2011; 33:443-453.
25. Richardson LP, Russo JE, Lozano P, Mc-Cauley E, Katon W: The effect of comor-bid anxiety and depressive disorders on health care utilization and costs among adolescents with asthma. Gen Hosp Psychiatry 2008; 30:398-406.
26. Haschke A, Hutter N, Baumeister H: Indirect costs in patients with coronary artery disease and mental disorders: a systematic review and meta-analysis. Int J Occup Med Environ Health 2012; 25: 319-329.
27. Holden L, Scuffham PA, Hilton MF, Ware RS, Vecchio N, Whiteford HA: Health-related productivity losses increase when the health condition is co-morbid with psychological distress: findings from a large cross-sectional sample of working Australians. BMC Public Health 2011; 11:417.
28. O'Neil A, Williams ED, Stevenson CE, Oldenburg B, Sanderson K: Co-morbid depression is associated with poor work outcomes in persons with cardiovascular disease (CVD): a large, nationally representative survey in the Australian population. BMC Public Health 2012; 12: 47.
29. Stein MB, Cox BJ, Afifi TO, Belik SL, Sareen J: Does co-morbid depressive illness magnify the impact of chronic physical illness? A population-based perspective. Psychol Med 2006; 36:587-596.
30. Kivimäki M, Vahtera J, Pentti J, Vir-tanen M, Elovainio M, Hemingway H: Increased sickness absence in diabetic employees: what is the role of co-morbid conditions? Diabet Med 2007; 24:1043-1048.
31. Druss BG, Rosenheck RA, Sledge WH: Health and disability costs of depressive illness in a major U.S. corporation. Am J Psychiatry 2000; 157:1274-1278.
32. Das-Munshi J, Stewart R, Ismail K, Beb-bington PE, Jenkins R, Prince MJ: Diabetes, common mental disorders, and disability: findings from the UK National Psychiatric Morbidity Survey. Psycho-som Med 2007; 69:543-550.
33. Katon W, Russo J, Lin EH, Schmittdiel J, Ciechanowski P, Ludman E, et al: Cost-effectiveness of a multicondition collaborative care intervention: a randomized controlled trial. Arch Gen Psychiatry 2012; 69:506-514.
34. Hay J, Katon W, Ell K, Lee PJ, Guterman J: Cost-effectiveness analysis of collaborative care management of major depression among low income, predominantly Hispanics with diabetes. Value Health 2012; 15:249-254.
35. King D, Molosankwe I, McDaid D: Collaborative care for depression in individuals with type II diabetes; in Knapp M, McDaid D, Parsonage M (eds): Mental Health Promotion and Mental Illness Prevention: The Economic Case. London, Department of Health, 2011.
36. Park AL, McDaid D, Weiser P, Von Gottberg C, Becker T, Kilian R: Examining the cost effectiveness of interventions to promote the physical health of people with mental health problems: a systematic review. BMC Public Health 2013; 13:787.
37. McDaid D: Economic modelling for global mental health; in Thornicroft G, Patel V (eds): Global Mental Health Trials. Oxford, Oxford University Press, 2014.
38. Park AL: Exploring the economic implications of a group-based lifestyle intervention for middle-aged adults with chronic schizophrenia and co-morbid type 2 diabetes. J Diabetes Metab 2014; 5:366.
39. Knapp M, McDaid D, Amaddeo F, Con-stantopoulos A, Oliveira MD, Salvador-Carulla L, et al: Financing mental health care in Europe. J Ment Health 2007; 16: 167-180.